SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-261344
Filing Date
2020-10-01
Accepted
2020-10-01 16:30:54
Documents
13
Period of Report
2020-09-25
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d38272d8ka.htm   iXBRL 8-K/A 31303
2 EX-16.1 d38272dex161.htm EX-16.1 1889
  Complete submission text file 0001193125-20-261344.txt   166394

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acet-20200925.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20200925_lab.xml EX-101.LAB 19601
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20200925_pre.xml EX-101.PRE 12302
6 EXTRACTED XBRL INSTANCE DOCUMENT d38272d8ka_htm.xml XML 3885
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38359 | Film No.: 201216337
SIC: 2834 Pharmaceutical Preparations